期刊文献+

盐酸氨柔比星的新合成工艺 被引量:2

New Synthetic Process of Amrubicin Hydrochloride
原文传递
导出
摘要 本研究报道了一种合成盐酸氨柔比星的新工艺。以(R)-2-乙酰基-2-三氟乙酰胺基-5,8-二甲氧基-1,2,3,4-四氢萘(12)与邻苯二甲酰氯发生傅-克酰化后,经新戊二醇羰基保护、1,3-二溴-5,5-二甲基海因(DBDMH)光化环合和盐酸水解得(7S,9S)-9-乙酰基-9-氨基-6,7,11-三羟基-7,8,9,10-四氢-并四苯-5,12-二酮(6)。6与2-脱氧-1,3,4-三-O-乙酰基-β-D-赤-吡喃戊糖在三氟甲磺酸三甲基硅酯作用下进行糖苷化反应,然后经氢氧化钾脱乙酰基、成盐得目标化合物,总收率10.7%,纯度达99.8%。本工艺操作便捷,后处理简单,产品纯度高。其中,由化合物12制备6的方法未见文献报道。 A new synthetic process of amrubicin hydrochloride was reported. (7S,9S)-9-Acetyl-9-amino- 6,7,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione (6) was obtained from (R)-2-acetyl-2-trifluoroacetamido-5,8- dimethoxy-1,2,3,4-tetrahydronaphthalene (12) via Friedel-Crafts acylation with phthaloyl chloride, ketalization of the carbonyl group with neopentylglycol, photochemical cyclization with 1,3-dibromo-5,5-dimethylhydantoin (DBDMH) and hydrolysis with hydrochloric acid sequentially. Then compound 6 was sujected to glycosidation with 2-deoxy-1,3,4- tri-O-acyl-β-D-erythro-pentopyranose in the presence of trimethylsilyl trifluoromethanesulfonate, deprotection of the acetyl groups and salification to prepare amrubicin hydrochloride with a total yield of 10.7 % and a purity of 99.8 %. This process has some advantages such as convenient operation, simple work-up, and high purity, and the synthetic method for compound 6 from 12 has not yet been reported in literature.
作者 游军辉 王俊亮 曹金 余俊 杜祖银 YOU Junhui;WANG Junliang;CAO Jin;YU Jun;DU Zuyin(Jiangsu Hansoh Pharmaceutical Co., Ltd., Lianyungang 22200)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2018年第7期927-932,共6页 Chinese Journal of Pharmaceuticals
关键词 盐酸氨柔比星 抗肿瘤药 傅-克酰化 光化反应 合成 amrubicin hydrochloride antineoplastic drug Friedel-Crafts acylation photochemical reaction synthesis
  • 相关文献

参考文献4

二级参考文献24

  • 1袁永荣,常萍.肺癌用药盐酸氨柔比星[J].齐鲁药事,2004,23(5):61-61. 被引量:6
  • 2Ogawa M. Novel anticancer drugs in Japan [J]. J Cancer Res Clin Oncol, 1999, 125 (3-4): 134-140.
  • 3Kurata T, Okamoto I, Tamura K, et al. Amrubicin for non-small-cell lung cancer and small-cell lung cancer [J]. Invest NewDrugs, 2007, 25(5): 499-504.
  • 4Yokota S, Negoro S, Yana T, et al. Phase II study of amrubicin (SM-5887), a 9-amino-anthracycline, in previously untreated paitents with extensive stage small-cell cancer(ES-SCLC) : A West Japan Lung Cancer Group Trial [J]. ProcAm Soc Clin Oncol, 1998, 17 (1) : 450.
  • 5Tririya G, Zanger M. Synthesis of anthracyclinone precursor: 5,12-dihydroxy- 1,3,4-trihydronaphthacene-2,6,11 -quinone [J]. Synth Commun, 2004, 34 (17): 3047-3059.
  • 6Alexander J, Mitscher LA. A short, efficient synthesis of an anthracycline antitumor antibiotic synthon [J]. Tetrahedron Lett, 1978, 19(37):3403-3406.
  • 7Lewis TR, Dickinson WB, Archer S. 1,4-Dimethoxy-5- methyl-6-tetralone and 1,4-dimethoxy-5,5-dimethyl-6- tetralone [J]. JAm Chern Soc, 1952, 74 (21) : 5321-5324.
  • 8Kende AS. 5,12-Epoxy-naphthacene-6,11-dione derivatives: US, 4116981 [P] 1978-09-26. (CA 1978, 90: 87251).
  • 9Nixon JA, Pioch RP, Schaus JM, et al. Ring-substituted 2-amino-l,2,3,4-tetarhydronaphthalenes: US, 5026707 [P]. 1989-11-26. (CA 1989, 112: 235346).
  • 10Arvidsson LE, Hacksell U, Johansson A, et al. 8-Hydroxy- 2-(alkylamino) tetralins and related compounds as central 5-hydroxytryptamine receptor agonists [J]. J Med Chem, 1984, 27(1): 45-51.

共引文献6

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部